New research in JNCCN finds telemedicine cons

Plymouth, Pennsylvania Meeting [May 8, 2023] — New research in the May 2023 issue JNCCN – Journal of the National Comprehensive Cancer Network Researchers at Moffitt Cancer Center found telemedicine consistently superior to in-person visits in both access to care and provider responsiveness, according to a long-term study of patient experiences . The researcher analyzed survey responses from 39,268 patients in more than 50,000 visits. The telemedicine experience was compared to in-person visits during and after her COVID-19 pandemic from 1 April 2020 to 30 June 2021.

“The pandemic has forced a reorganization of valuable health care resources. Providers caring for cancer patients needed innovative approaches for high-quality, timely care,” said the principal investigator. said. Krupal B. Patel, MD, MSc, Moffitt Cancer Center“As an anecdote, we knew from clinical provider feedback that our telemedicine implementation was effective and efficient. The patient experience study provided us with an opportunity to study this in more detail.”

Researchers examined Press Ganey survey data from 33,318 patients who had in-person appointments and 5,950 patients who had telemedicine appointments. Regarding access to care, 62.5% of him rated in-person visits as very satisfied, compared to 75.8% for telemedicine. Response rates were 84.2% for face-to-face care and 90.7% for telemedicine, indicating high satisfaction with the level of care and concern shown by providers. There were no significant changes over time in any category.

“Telemedicine visits can be incorporated into a patient’s daily schedule, so appointments can be completed before, during, or after work. It provides flexibility and ultimately increases access.” added the senior researcher. Philippe E. Spiess, MD, MS, Moffitt Cancer Center, bladder/penis cancer“As health care providers, we must lead the debate and advocate for both interstate licensing and telemedicine continued reimbursement on behalf of patients.”

“Many of our institutions have been forced to adopt telemedicine in response to the COVID-19 pandemic. It shows that it was similar or better, ”he commented. Travis Osterman, DO, MS, FAMIA, FASCO, Vice President of Research Informatics, Vanderbilt University Medical Center, Member of the NCCN EHR Oncology Advisory Group— was not involved in this research. “Going forward, oncology practices should consider telemedicine as an option for suitable patients.”

This study also references previous research on the healthcare provider’s perspective on telemedicine and its potential to reduce costs such as transportation, parking, and housing arrangements.^[1],[2]However, researchers note that not all oncology visits should be virtual. Careful patient selection is important to determine which patients should be seen in person for testing and other treatments.

To read the entire study, please visit: JNCCN.orgFree access to .Adoption of Telemedicine at NCI Designated Cancer Centers During the COVID-19 Pandemic: A Report on the Patient Care Experienceis available until August 10, 2023.

# # #

almost JNCCN – Journal of the National Comprehensive Cancer Network

Read by more than 25,000 oncologists and other cancer care professionals nationwide. JNCCN – Journal of the National Comprehensive Cancer NetworkThis peer-reviewed, indexed medical journal provides the latest information on innovations in translational medicine and oncology, including intervention research on quality care and value, bioethics, comparative and cost-effectiveness, public policy, and supportive care. Provides scientific research related to academic health services research. and survive. JNCCN Provides the latest information from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines).^®), articles detailing guideline recommendations, health services research, and case reports focused on molecular insights in patient care. JNCCN Published by Harborside.visit JNCCN.orgTo inquire about eligibility free subscribe to JNCCNvisit NCCN.org/jnccn/subscribe. follow JNCCN on Twitter @JNCCN.

About National Comprehensive Cancer Network

National Comprehensive Cancer Network^® (NCCN^®) non-profit alliance. major cancer centers Dedicated to patient care, research and education. NCCN is committed to improving and promoting quality, effective, equitable, and accessible cancer care so that all patients can live better lives.NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) Provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and support services. They are the recognized standard for clinical direction and policy in cancer management and are the most complete and frequently updated clinical practice guidelines available in any medical field.NCCN Guidelines for Patients^® Providing professional cancer care information to inform and empower patients and caregivers through support from. NCCN Foundation^®NCCN also advances continuing education, global initiatives, policies, research collaborations and publications in oncology.visit NCCN.org For more information.

[1] Turner K, Bobonis Babylonia M, Naso C, et al. Experiences of healthcare providers and professionals in implementing telemedicine oncology during the COVID-19 pandemic: a qualitative survey. J Med Internet Res 2022;24:e29635.

[2] Patel KB, Turner K, Alishahi Tabriz A, et al. Estimated overhead savings from the use of telemedicine in non-elderly cancer patients. JAMA net opened. 2023;6(1):e2250211.doi:10.1001/jamanetworkopen.2022.50211